Valuation: AtriCure, Inc.

Market Cap 3.12B 2.8B 2.59B 2.35B 4.38B 298B 4.44B 30.99B 12.34B 156B 11.72B 11.48B 494B P/E 2026 *
575x
P/E 2027 * 146x
Enterprise Value 2.97B 2.67B 2.47B 2.23B 4.17B 283B 4.22B 29.48B 11.74B 148B 11.15B 10.92B 470B EV / Sales 2026 *
4.9x
EV / Sales 2027 * 4.26x
Free-Float
96.24%
Yield 2026 *
-
Yield 2027 * -
1 day-0.15%
1 week+6.50%
Current month+9.29%
1 month+5.15%
3 months+54.52%
6 months+115.66%
Current year+55.26%
1 week 58.53
Extreme 58.53
63
1 month 51.63
Extreme 51.63
63
Current year 25.36
Extreme 25.36
63
1 year 25.36
Extreme 25.36
63
3 years 18.94
Extreme 18.94
63
5 years 18.94
Extreme 18.94
89.18
10 years 14.78
Extreme 14.78
89.18
Manager TitleAgeSince
Chief Executive Officer 55 02/11/2012
Director of Finance/CFO 48 01/07/2014
Chief Tech/Sci/R&D Officer 59 18/07/2017
Director TitleAgeSince
Director/Board Member 55 02/11/2012
Director/Board Member 64 11/03/2013
Director/Board Member 75 10/11/2016
Date Insider Type Main position Quantity % Market Cap. Importance
9/23/26 A Sell

Chief Technology Officer

-4,519 0.0089%
9/11/26 A Sell

Director

-5,313 0.0104%
9/8/26 A Sell

Chief Technology Officer

-3,657 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
-0.15%+6.50%+68.50%+84.22% 3.13B
-0.45%+2.12%-18.93%+10.54% 178B
+0.86%+2.15%-19.13%+16.07% 116B
+0.88%+1.88%+1.66%+36.51% 115B
-2.26%+2.24%-44.03%+5.76% 93.1B
-0.31%-4.72%-3.36%+72.86% 62.09B
0.00%+0.08%+10.67%+84.29% 55.87B
+0.07%+0.42%+5.94%-22.43% 53.12B
+0.30%+1.70%-11.26%+43.83% 44.22B
+0.10%+3.08%-3.06%-8.71% 33.59B
Average -0.10%+3.56%-1.30%+32.29% 75.41B
Weighted average by Cap. -0.12%+3.71%-12.17%+24.43%

Financials

2026 *2027 *
Net sales 606M 544M 503M 455M 851M 57.74B 861M 6.01B 2.39B 30.21B 2.28B 2.23B 95.92B 680M 610M 564M 511M 955M 64.79B 966M 6.75B 2.69B 33.9B 2.55B 2.5B 108B
Net income 7.13M 6.4M 5.92M 5.36M 10.01M 679M 10.13M 70.74M 28.17M 355M 26.76M 26.2M 1.13B 20.89M 18.74M 17.33M 15.69M 29.31M 1.99B 29.67M 207M 82.51M 1.04B 78.38M 76.72M 3.3B
Net Debt -152M -136M -126M -114M -213M -14.47B -216M -1.51B -600M -7.57B -570M -558M -24.03B -227M -203M -188M -170M -318M -21.58B -322M -2.25B -895M -11.29B -850M -832M -35.85B
Projected Income Statement - Annual - AtriCure, Inc.
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
28/10/26 $61.42 -0.15% 647,549
27/10/26 $61.51 +0.70% 783,200
26/10/26 $61.08 +3.58% 816,229
23/10/26 $58.97 -0.56% 497,155
22/10/26 $59.30 +2.83% 498,177
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - AtriCure, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
61.42USD
Average target price
57.56USD
Spread / Average Target
-6.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - AtriCure, Inc.
  1. Stock Market
  2. Stocks
  3. ATRC Stock